Align Technology Announces Fourth Quarter and Fiscal 2007 Results
SANTA CLARA, Calif., Jan 29, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Align Technology, Inc. (Nasdaq: ALGN) today reported financial results for the fourth quarter and fiscal year 2007, ended December 31, 2007.
Total net revenues for the fourth quarter of fiscal 2007 (Q4 07) were $72.5 million. This reflects a year-over-year increase of 31 percent compared to $55.2 million in the fourth quarter of 2006 (Q4 06). On a sequential basis, net revenues increased slightly from $71.5 million in the third quarter of 2007 (Q3 07). For fiscal 2007, net revenues of $284.3 million increased 38 percent from $206.4 million reported for fiscal 2006.
"Our fourth quarter results were a strong finish to an outstanding year in which revenue and profitability were well ahead of our original outlook," said Thomas M. Prescott, president and CEO of Align Technology. "We're entering 2008 with a robust product development pipeline, including Vivera Retainers, Invisalign Teen and Invisalign ClinAssist, which will lay the foundation for long term growth."
On a generally accepted accounting principles (GAAP) basis, net profit for Q4 07 was $5.7 million, or $0.08 per diluted share. This reflects a significant increase from a GAAP net loss of $17.3 million, or $0.27 loss per diluted share in Q4 06, and a decrease in GAAP net profit from $9.5 million, or $0.13 per diluted share in Q3 07. GAAP net profit for fiscal 2007 was $35.7 million, or $0.50 per diluted share. This compares to a net loss of $35.0 million, or $0.55 loss per diluted share in fiscal 2006.
Non-GAAP net profit for Q4 07 was $9.3 million or $0.13 per diluted share. This reflects a significant increase from a non-GAAP net loss of $0.8 million, or $0.01 loss per diluted share in Q4 06, and a decrease in non-GAAP net profit from $12.6 million, or $0.17 per diluted share in Q3 07. Non-GAAP net profit for fiscal 2007 was $45.9 million or $0.64 per diluted share. This compares to a non-GAAP net loss of $11.7 million or $0.19 loss per diluted share in fiscal 2006.
Non-GAAP financial measures should be considered in addition to results prepared in accordance with GAAP, but should not be considered a substitute for, or superior to, GAAP results. A detailed reconciliation between GAAP and non-GAAP information is contained in the tables following the financial tables of this release.
Q4 07 Operating Results Key GAAP Operating Results Q4 07 Q3 07 Q4 06 Gross Margin 73.6% 74.6% 68.8% Operating Expense $48.4M $44.9M $56.1M Net Profit (Loss) $5.7M $9.5M ($17.3M) Earnings (Loss) Per Diluted Share (EPS) $0.08 $0.13 ($0.27) Key Non-GAAP Operating Results Q4 07 Q3 07 Q4 06 Non-GAAP Gross Margin 74.0% 75.0% 69.2% Non-GAAP Operating Expense $45.2M $41.8M $39.7M Non-GAAP Net Profit (Loss) $9.3M $12.6M ($0.8M) Non-GAAP Earnings (Loss) Per Diluted Share $0.13 $0.17 ($0.1)
Liquidity and Capital Resources
As of December 31, 2007, Align had $127.9 million in cash, cash equivalents, marketable securities and restricted cash, compared to $64.1 million as of December 31, 2006.
Key Business Metrics
The following table highlights business metrics for Align's fourth quarter of 2007. Additional historical information is available on the Company's website at investor.aligntech.com.
Revenue by Channel: Q4 07 Q4'07/Q3'07 Q4'07/Q4'06 % Change % Change U.S. Orthodontists $21.4M (4.9%) 23.0% U.S. GP Dentists $33.5M (3.7%) 36.7% International $14.2M 22.4% 47.9% Training and Other $3.4M 30.8% (8.1%) Total Revenue $72.5M 1.4% 31.3% Average Selling Price (ASP): Q4 07 Q4'07/Q3'07 Q4'07/Q4'06 % Change % Change Total Worldwide Blended ASP $1,360 3.0% 3.0 Total Worldwide ASP excluding Invisalign Express $1,470 2.8% 1.7 U.S. Orthodontists Blended ASP $1,240 0.8% 2.1 U.S. GP Dentists Blended ASP $1,320 0.8% 2.7 International $1,760 11.4% 2.0 Number of Cases Shipped: Q4 07 Q4'07/Q3'07 Q4'07/Q4'06 % Change % Change U.S. Orthodontists - Full Invisalign 14,270 (5.8%) 22.3% U.S. Orthodontists - Invisalign Express 3,060 (2.2%) 13.3% U.S. GP Dentists - Full Invisalign 20,800 (4.9%) 37.3% U.S. GP Dentists - Invisalign Express 4,630 0.7% 16.9% International - Full Invisalign 7,950 11.0% 47.2% International - Invisalign Express 120 (7.7%) (14.3%) Total Cases Shipped 50,830 (2.3%) 30.3% Number of Doctors Cases were Shipped to: Q4 07 U.S. Orthodontists 3,640 U.S. GP Dentists 10,040 International 2,510 Total Doctors Cases were Shipped to Worldwide 16,190 Number of Doctors Trained Worldwide: Q4 07 Cumulative U.S. Orthodontists 80 8,310 U.S. GP Dentists 1,500 27,480 International 500 12,340 Total Doctors Trained Worldwide 2,080 48,130 Multiple Case Doctors (Cumulative as of): Q4 07 U.S. Orthodontists 89.7% U.S. GP Dentists 87.1% International 76.4% Doctors Starting Invisalign Treatment Q4 07 (Cumulative as of): U.S. Orthodontists 6,710 U.S. GP Dentists 21,600 International 6,610 Total Doctors Starting Invisalign Treatment 34,920 Doctor Utilization Rates*: Q4 07 Q3 07 Q4 06 U.S. Orthodontists 4.8 4.9 4.2 U.S. GP Dentists 2.5 2.6 2.4 International 3.2 3.1 2.9 Total Utilization Rate 3.1 3.2 2.9 * Utilization = # of cases/# of doctors to whom cases were shipped
Align also recently announced that it has consolidated and re-branded the Company's extensive clinical education programs and launched a new, interactive web site to provide a suite of scalable, diverse educational resources and programs for prospective, recently certified and advanced Invisalign providers. The centerpiece of the new end-to-end approach to clinical education is http://www.AligntechInstitute.com, a dynamic, interactive web site with Invisalign product support, industry news and insights, instructor-led and web-based CE events and more.
As announced on January 9, 2008, Align Technology is expected to deliver new products in 2008 with features such as staged delivery with Invisalign ClinAssist and replacement aligners included with Invisalign Teen. These new products will have a significantly higher amount of deferred revenue as a percentage of their average selling price. Therefore, as new products increase as a percentage of total net revenues in the latter part of 2008, deferred revenue on the balance sheet will increase substantially and will be recognized as revenue in future periods.
For the first quarter 2008 (Q1 08), Align Technology expects net revenues to be in a range of $70.4 million to $73.0 million. Earnings per diluted share for Q1 08 is expected to be in a range of $0.01 to $0.03. Stock-based stock compensation expense for Q1 08 is expected to be approximately $3.7 million.
For fiscal 2008, Align Technology expects net revenues to be in a range of $320.0 million to $330.0 million. This reflects an increase in deferred revenue of $9 million to $18 million primarily associated with new products, which will be recognized in future periods, bringing the Company's total deferred revenue balance at the end of 2008 to a range of $20 million to $30 million. Earnings per diluted share for fiscal 2008 is expected to be in a range of $0.40 to $0.45. Stock-based compensation expense for fiscal 2008 is expected to be approximately $18.0 million.
A more comprehensive business outlook is available following the financial tables of this release.
Align Web cast and Conference Call
Align Technology will host a conference call today, January 29, 2008 at 4:30 p.m. ET, 1:30 p.m. PT, to review its fourth quarter and fiscal 2007 results, discuss future operating trends and business outlook. The conference call will also be webcast live via the Internet. To access the webcast, go to the "Events & Presentations" section under Company Information on Align Technology's Investor Relations web site at http://investor.aligntech.com. To access the conference call, please dial 201-689-8341 approximately fifteen minutes prior to the start of the call. If you are unable to listen to the call, an archived web cast will be available beginning approximately one hour after the call's conclusion and will remain available for approximately 12 months. Additionally, a telephonic replay of the call can be accessed by dialing 877-660-6853 with account number 292 followed by # and conference number 268148 followed by #. The replay must be accessed from international locations by dialing 201-612-7415 and using the same account and conference numbers referenced above. The telephonic replay will be available through 4:30 p.m. ET on February 12, 2008.
About Align Technology, Inc.
Align Technology designs, manufactures and markets Invisalign, a proprietary method for treating malocclusion, or the misalignment of teeth. Invisalign corrects malocclusion using a series of clear, nearly invisible, removable appliances that gently move teeth to a desired final position. Because it does not rely on the use of metal or ceramic brackets and wires, Invisalign significantly reduces the aesthetic and other limitations associated with braces. Invisalign is appropriate for treating adults and older teens. Align Technology was founded in March 1997 and received FDA clearance to market Invisalign in 1998.
To learn more about Invisalign or to find a certified Invisalign doctor in your area, please visit http://www.invisalign.com or call 1-800-INVISIBLE.
About Non-GAAP Financial Measures
To supplement our consolidated financial statements, which are prepared and presented in accordance with generally accepted accounting principals (GAAP), we use the following non-GAAP financial measures: non-GAAP gross profit, gross margin, profit (loss) from operations, net profit (loss), earnings (loss) per share, and operating expenses, which exclude stock-based compensation and the Patients First Program. The presentation of this financial information is not intended to be considered in isolation or as a substitute for, or superior to, the financial information prepared and presented in accordance with GAAP. For more information on these non-GAAP financial measures, please see the tables captioned "Reconciliation of GAAP to Non-GAAP Key Financial Metrics" and "Business Outlook Summary" included at the end of this release.
We use these non-GAAP financial measures for financial and operational decision making and as a means to evaluate period-to-period comparisons. Our management believes that these non-GAAP financial measures provide meaningful supplemental information regarding our "core operating performance." Management believes that "core operating performance" represents Align's performance in the ordinary, ongoing and customary course of its operations. Accordingly, management excludes from "core operating performance" certain expenses and expenditures that may not be indicative of our operating performance including not only non-cash charges, such as stock-based compensation, but also discrete cash charges that are infrequent or one-time in nature. We believe that both management and investors benefit from referring to these non-GAAP financial measures in assessing our performance and when planning, forecasting and analyzing future periods. These non-GAAP financial measures also facilitate management's internal evaluation of period-to-period comparisons. We believe these non-GAAP financial measures are useful to investors both because (1) they allow for greater transparency with respect to key metrics used by management in its financial and operational decision making and (2) they are provided to and used by our institutional investors and the analyst community to help them analyze the health of our business.
In addition to the reasons stated above, which are generally applicable to each of the items we exclude from our non-GAAP financial measures, we believe it is appropriate to exclude Stock-Based Compensation for the following reasons. Align adopted SFAS 123(R), beginning in its fiscal year 2006. When evaluating the performance of our business, we do not consider stock-based compensation charges. In contrast, we do consider and managers are held accountable for cash-based compensation and such amounts are included in our operating plan. Further, when considering the impact of equity award grants, Align places a greater emphasis on overall shareholder dilution rather than the accounting charges associated with such grants.
This news release, including the tables below, contains forward-looking statements, including statements regarding Align's anticipated financial results and certain business metrics for the first quarter and full year of 2008, including anticipated revenue and deferred revenue, gross profit, gross margin, operating expense, net profit, earnings per share, percentage of revenue by channel, case shipments and average selling prices and statements regarding the anticipated introduction of Invisalign ClinAssist and Invisalign Teen and the expectation that these new products will increase as a percentage of sales in the later part of 2008. Forward-looking statements contained in this news release and the tables below relating to expectations about future events or results are based upon information available to Align as of the date hereof. Readers are cautioned that these forward-looking statements are only predictions and are subject to risks, uncertainties and assumptions that are difficult to predict. As a result, actual results may differ materially and adversely from those expressed in any forward-looking statement. Factors that might cause such a difference include, but are not limited to, the possibility that the development and release of new products does not proceed in accordance with the anticipated timeline, the possibility that the market for the sale of these new products may not develop as expected, the risks relating to Align's ability to sustain or increase profitability or revenue growth in future periods while controlling expenses, continued customer demand for Invisalign and new products, the timing of case submissions from our doctors within a quarter, acceptance of Invisalign by consumers and dental professionals, Align's third party manufacturing processes and personnel, foreign operational, political and other risks relating to Align's international manufacturing operations, Align's ability to protect its intellectual property rights, competition from manufacturers of traditional braces and new competitors, Align's ability to develop and successfully introduce new products and product enhancements, and the loss of key personnel. These and other risks are detailed from time to time in Align's periodic reports filed with the Securities and Exchange Commission, including, but not limited to, its Annual Report on Form 10-K for the fiscal year ended December 31, 2006, which was filed with the Securities and Exchange Commission on March 12, 2007, and its Quarterly Reports on Form 10-Q. Align undertakes no obligation to revise or update publicly any forward-looking statements for any reason.
Investor Relations Contact Press Contact Shirley Stacy Shannon Mangum Henderson Align Technology, Inc. Ethos Communication, Inc. (408) 470-1150 (678) 540-9222 email@example.com firstname.lastname@example.org ALIGN TECHNOLOGY, INC. UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (in thousands, except per share data) Three Months Ended Year Ended December December December December 31, 2007 31, 2006 31, 2007 31, 2006 Net revenues $72,517 $55,191 $284,332 $206,354 Cost of revenues 19,127 17,197 75,035 64,775 Gross profit 53,390 37,994 209,297 141,579 Operating expenses: Sales and marketing 26,502 22,121 98,231 81,993 General and administrative 15,266 14,649 53,280 64,305 Research and development 6,610 4,948 25,727 18,474 Patients First Program - 14,343 (1,796) 14,343 Total operating expenses 48,378 56,061 175,442 179,115 Profit (loss) from operations 5,012 (18,067) 33,855 (37,536) Interest and other income, net 852 1,008 3,095 3,401 Profit (loss) before income taxes 5,864 (17,059) 36,950 (34,135) Provision for income taxes (196) (210) (1,226) (828) Net profit (loss) $5,668 $(17,269) $35,724 $(34,963) Net profit (loss) per share - basic $0.08 $(0.27) $0.53 $(0.55) - diluted $0.08 $(0.27) $0.50 $(0.55) Shares used in computing net profit (loss) per share - basic 68,562 64,252 67,176 63,246 - diluted 71,864 64,252 71,444 63,246 ALIGN TECHNOLOGY, INC. UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (in thousands) December 31, December 31, 2007 2006 ASSETS Current assets: Cash and cash equivalents $89,119 $55,113 Restricted cash 21 93 Marketable securities, short-term 38,771 8,931 Accounts receivable, net 44,850 33,635 Inventories, net 2,910 3,090 Other current assets 8,846 7,227 Total current assets 184,517 108,089 Property and equipment, net 25,320 26,904 Goodwill and intangible assets, net 11,093 14,302 Other long-term assets 1,831 2,263 Total assets $222,761 $151,558 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Line of credit $- $11,500 Accounts payable 9,222 5,034 Accrued liabilities 39,875 40,307 Deferred revenue 12,362 10,942 Total current liabilities 61,459 67,783 Other long term liabilities 148 219 Total liabilities 61,607 68,002 Total stockholders' equity 161,154 83,556 Total liabilities and stockholders' equity $222,761 $151,558 ALIGN TECHNOLOGY, INC. RECONCILIATION OF GAAP TO NON-GAAP KEY FINANCIAL METRICS Reconciliation of GAAP to Non-GAAP Gross Profit (in thousands, except percentages) Three Months Ended December 31, September 30, December 31, 2007 2007 2006 GAAP Gross profit $53,390 $53,319 $37,994 Stock based compensation expense 291 259 185 Non-GAAP Gross profit $53,681 $53,578 $38,179 Non-GAAP Gross margin 74.0% 75.0% 69.2% Reconciliation of GAAP to Non-GAAP Operating Expenses (in thousands) Three Months Ended December 31, September 30, December 31, 2007 2007 2006 GAAP Operating expenses $48,378 $44,924 $56,061 Stock based compensation expense 3,145 3,129 1,977 Patients First Program - - 14,343 Non-GAAP Operating expenses $45,233 $41,795 $39,741 Reconciliation of GAAP to Non-GAAP Net Profit (Loss) (in thousands, except per share amounts) Three Months Ended December 31, September 30, December 31, 2007 2007 2006 GAAP Net profit (loss) $5,668 $9,460 $(17,269) Stock based compensation expense 3,436 3,388 2,162 Patients First Program - - 14,343 Tax effect of stock based compensation expense 160 (261) - Non-GAAP Net profit (loss) $9,264 $12,587 $(764) Diluted Net profit (loss) per share: GAAP $0.08 $0.13 $(0.27) Non-GAAP $0.13 $0.17 $(0.01) Shares used in computing diluted net profit (loss) per share 71,864 72,230 64,252 Summary of Stock Based Compensation Expense (in thousands) Three Months Ended December 31, September 30, December 31, 2007 2007 2006 Cost of revenues $291 $259 $185 Sales and marketing 1,169 1,301 737 General and administrative 1,508 1,403 922 Research and development 468 425 318 Total stock based compensation expense $3,436 $3,388 $2,162 ALIGN TECHNOLOGY, INC. RECONCILIATION OF GAAP TO NON-GAAP KEY FINANCIAL METRICS Reconciliation of GAAP to Non-GAAP Gross Profit (in thousands, except percentages) Years Ended December 31, December 31, 2007 2006 GAAP Gross profit $209,297 $141,579 Stock based compensation expense 994 700 Non-GAAP Gross profit $210,291 $142,279 Non-GAAP Gross margin 74.0% 68.9% Reconciliation of GAAP to Non-GAAP Operating Expenses (in thousands) Years Ended December 31, December 31, 2007 2006 GAAP Operating expenses $175,442 $179,115 Stock based compensation expense 11,217 8,210 Patients First Program (1,796) 14,343 Non-GAAP Operating expenses $166,021 $156,562 Reconciliation of GAAP to Non-GAAP Net Profit (Loss) (in thousands, except per share amounts) Years Ended December 31, December 31, 2007 2006 GAAP Net profit (loss) $35,724 $(34,963) Stock based compensation expense 12,211 8,910 Patients First Program (1,796) 14,343 Tax effect of stock based compensation expense (214) - Non-GAAP Net profit (loss) $45,925 $(11,710) Diluted Net profit (loss) per share: GAAP $0.50 $(0.55) Non-GAAP $0.64 $(0.19) Shares used in computing diluted net profit (loss) per share 71,444 63,246 Summary of Stock Based Compensation Expense (in thousands) Years Ended December 31, December 31, 2007 2006 Cost of revenues $994 $700 Sales and marketing 4,225 2,862 General and administrative 5,443 4,054 Research and development 1,549 1,294 Total stock based compensation expense $12,211 $8,910 ALIGN TECHNOLOGY, INC. BUSINESS OUTLOOK SUMMARY (unaudited)
The outlook figures provided below and elsewhere in this press release are approximate in nature since Align's business outlook is difficult to predict. Align's future performance involves numerous risks and uncertainties and the company's results could differ materially from the outlook provided. Some of the factors that could affect Align's future financial performance and business outlook are set forth under "Forward Looking Information" above in this press release.
Financials: (in millions, except per share amounts and percentages) Q1 2008 FY 2008 Net Revenue $70.4 - $73.0 $320.0 - $330.0 Gross Profit $50.8 - $53.5 $237.6 - $248.0 Gross Margin 72.2% - 73.2% 74.2% - 75.1% Operating Expenses $50.4 - $51.9 $210.8 - $218.8 Net Profit $0.7 - $2.2 $29.3 - $32.7 Net Profit % 1% - 3% 9% - 10% Net Profit per Diluted Share $0.01 - $0.03 $0.40 - $0.45 Increase in Deferred Revenue $9.0 - $18.0 Total Deferred Revenue Balance $20.0 - $30.0 Stock Based Compensation Expense: Cost of Revenues $0.3 $1.2 Operating Expenses $3.4 $16.8 Total Stock Based Compensation Expense $3.7 $18.0 Business Metrics: Q1 2008 FY 2008 Case Shipments 50.0K - 51.5K 226.7K - 237.2K Cash $117M - $122M $160M - $170M DSO ~56 days ~56 days Capex $4.0M - $6.0M $10.0M - $14.0M Depreciation & Amortization $2.0M - $3.0M $13.0M - $14.0M Diluted Shares Outstanding 71.2M 73.2M
SOURCE Align Technology, Inc.
Copyright (C) 2008 PR Newswire. All rights reserved
News Provided by COMTEX